Experiences with
Metabolic conditions31,739 public posts
Want to take advantage of all our features? Just log in!
or
Skip and Mariana's Journey with Proton Therapy, Military Healthcare, and Prostate Cancer.
https://youtu.be/AF9B-7lv5BQ
Skip and Mariana share their emotional and informative journey through Skip's prostate cancer diagnosis and treatment decisions. The couple discusses their experience with proton therapy, the role of military healthcare, the financial implications of treatment, and the crucial
40 day Low carb meal plan (pdf)
https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.moatfield.co.uk/media/content/files/Low%2520carb%2520diet%2520plan.pdf&ved=2ahUKEwj8kNH7nMKJAxXlRKQEHRXEFtYQFnoECBoQAQ&usg=AOvVaw3KhvCkhjuJEPUU9DFGQ3mk
When I started my NO!vember challenge reducing carbs I came across this
Teva versus the rest
Background
The current Teva levothyroxine in the UK was introduced as a brand new formulation around 2016. (There was no Teva levothyroxine product for a few years - approximately 2012 to 2016.)
Teva introduced 12.5, 25, 50, 75 and 100 microgram dosages. These were the first 12.5 and 75 levothyroxine
NICE: Teprotumumab for treating thyroid eye disease ID 6432 - being scoped
setid=3e6c54a1-cefd-4a5b-a855-ab9f268b6cce
[i]Home > NICE Guidance > Conditions and diseases > Diabetes and other endocrinal, nutritional and metabolic conditions > Thyroid disorders[/i]
[i]Teprotumumab for treating thyroid eye disease ID 6432[/i]
[i][/i]
[i]Awaiting development [GID-TA11531